Business development models
Collaborations and business development are integral to our growth strategy and have played a key role in our complex generics and biosimilars business.
We seek partners for the following opportunities:
Out-licensing our biosimilars manufacturing technologies
Purchase of our finished biopharmaceuticals and bulk API
Establishing joint ventures for biosimilars production
Co-development of biopharmaceuticals